Most policies still exclude weight-loss medications under general exclusions unless they are part of the treatment of a ...

British Columbia's Health Ministry is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...

The B.C. government is restricting the sales of two more diabetes drugs to people outside Canada amid rising demand for the ...

National shareholders rights firm Hagens Berman continues to investigate the legal claims and urges Hims & Hers investors who suffered substantial losses to submit your losses now . The firm also ...

Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether using GLP-1 inhibitors could lessen the impacts of stroke and related brain ...

New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.

HONG KONG SAR - Media OutReach Newswire - 17 July 2025 - Cyberport successfully hosted the "AI x Data Forum" today. Centered on the theme "AI in Action, Data at the Core: Unlocking Infinite Potential" ...

Older age and female sex may be associated with greater muscle loss in adults with obesity prescribed semaglutide, and ...

HIMS benefits from strong online revenue, subscriber growth, and global expansion moves to fuel its health platform momentum. However, challenges may hurt performance.

PORTLAND, OR, UNITED STATES, July 17, 2025 /EINPresswire.com/ -- The global anti-obesity drugs market, valued at $1,605.36 million in 2022, is projected to reach $4,439.34 million by 2032, expanding ...